Ballard Spahr says the Hikma v. Amarin decision makes it harder for brand-name drugmakers to sue over "skinny label" generics — a shift likely to speed generic competition and lower costs for patients
|Articles|August 25, 2013
Medicaid must keep higher reimbursement rates
A letter writer argues for making Medicaid-Medicare reimbursement parity permanent.
Advertisement
If Medicaid is serious about attracting primary care physicians to take on new patients, the reimbursement rate cannot revert after 2014 (“Higher Medicaid payments coming soon,” July 10, 2013.) What’s the incentive for the physician other than a short-term bump in revenue? The hassles that come with Medicaid are not worth the effort.
Mike Robertson
Batesville, Indiana
Advertisement
Related to this article
CMS chief says outcomes-based pay can help patients while finally ending physicians' box-checking frustration.
What new EBRI research on 401(k) borrowers means for doctors still paying off med school
Preparing rural care teams for AI can strengthen care without replacing clinical judgement.
The 3-part federal plan targets costs, red tape and corporate consolidation across commercial health insurance.
Revenue per patient is a common way to split practice profit. It’s also the wrong way.
Advertisement
Advertisement
Trending on Medical Economics
1
What they're saying about the draft 2027 Medicare Physician Fee Schedule
2
Dr. Oz on ACCESS: Let’s treat patients instead of just checking boxes
3
Hiring more specialists alone won't shorten wait times, NEJM Catalyst analysis argues
4
AI in rural primary care: 6 questions physicians must answer with their nurses and APPs
5